Study on Varicella-Zoster Virus Antibody Levels among Children Aged 1-7 Years in Changzhou, China
- PMID: 38543925
- PMCID: PMC10974081
- DOI: 10.3390/vaccines12030290
Study on Varicella-Zoster Virus Antibody Levels among Children Aged 1-7 Years in Changzhou, China
Abstract
We aim to understand the varicella-zoster virus (VZV) antibody levels in children after vaccination and to construct VZV-IgG centile curves and reference values for children aged 1-7 years. From September to October 2023, a total of 806 children were recruited according to the time intervals of 1 month, 6 months, 1 year, 2 years, and 3 years after vaccination, as well as age groups. A generalized additive model for location, shape, and scale (GAMLSS) was applied to estimate P3, P10, P25, P50, P75, P90, and P97 centile reference values of VZV-IgG, and 95% reference intervals were calculated. A total of 785 children were included in the analysis, with an overall positivity rate of 70.3%, a median antibody concentration of 192.05 (82.89-571.14) mIU/mL, and a positivity rate of 57.7% for one dose of vaccine and 84.2% for two doses. Antibody positivity rates at 1 month, 6 months, 1 year, 2 years, and 3 years after vaccination were 65.1%, 74.4%, 80.4%, 67.7%, and 63.0%, respectively. The GAMLSS results showed that VZV-IgG had a tendency to increase and then decrease after vaccination, and the second dose of vaccination could significantly increase VZV-IgG. Two doses of varicella vaccine should be administered to children in a timely manner and included in the routine vaccination programs.
Keywords: GAMLSS; VZV-IgG; vaccination; varicella.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of this study; in the collection, analyses, or interpretation of data; in the writing of this manuscript; or in the decision to publish the results.
Figures




Similar articles
-
Prevention of varicella-zoster virus infection in early childhood children: effect of 1 versus 2 doses of varicella vaccine on antibody levels.Infection. 2025 Apr 7. doi: 10.1007/s15010-025-02532-w. Online ahead of print. Infection. 2025. PMID: 40192960
-
Vaccination against Varicella Zoster Virus Infection in Less Developed Regions of Guangdong, China: A Cross-Sectional Serosurveillance Study.Vaccines (Basel). 2023 Feb 21;11(3):494. doi: 10.3390/vaccines11030494. Vaccines (Basel). 2023. PMID: 36992078 Free PMC article.
-
[Seroepidemiology of varicella among the healthy population aged 1-19 years in Harbin, China].Zhongguo Dang Dai Er Ke Za Zhi. 2019 Mar;21(3):203-207. doi: 10.7499/j.issn.1008-8830.2019.03.003. Zhongguo Dang Dai Er Ke Za Zhi. 2019. PMID: 30907340 Free PMC article. Chinese.
-
Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1561-1569. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.052. Epub 2016 Apr 29. J Stroke Cerebrovasc Dis. 2016. PMID: 27138380 Free PMC article. Review.
-
Primary varicella zoster infection compared to varicella vaccine reactivation associated meningitis in immunocompetent children.J Paediatr Child Health. 2021 Jan;57(1):19-25. doi: 10.1111/jpc.15303. Epub 2020 Dec 8. J Paediatr Child Health. 2021. PMID: 33295075 Review.
Cited by
-
Analysis of sero-epidemiological characteristics of varicella in healthy children in Wuxi, China.Hum Vaccin Immunother. 2024 Dec 31;20(1):2432118. doi: 10.1080/21645515.2024.2432118. Epub 2024 Dec 5. Hum Vaccin Immunother. 2024. PMID: 39635720 Free PMC article.
-
Immunogenicity and safety of a live attenuated varicella vaccine in children aged 1 to 12 years: A double-blind, randomized, parallel-controlled phase III clinical trial in China.Hum Vaccin Immunother. 2025 Dec;21(1):2452681. doi: 10.1080/21645515.2025.2452681. Epub 2025 Feb 2. Hum Vaccin Immunother. 2025. PMID: 39895085 Free PMC article. Clinical Trial.
-
Seroepidemiological survey of the population 10 years after the implementation of the varicella vaccine 2-dose immunization strategy.Hum Vaccin Immunother. 2025 Dec;21(1):2512642. doi: 10.1080/21645515.2025.2512642. Epub 2025 Jun 4. Hum Vaccin Immunother. 2025. PMID: 40464766 Free PMC article.
References
-
- Freer G., Pistello M. Varicella-zoster virus infection: Natural history, clinical manifestations, immunity and current and future vaccination strategies. New Microbiol. 2018;41:95–105. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials